Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00361894
Status:
COMPLETED
Last Update Posted:
2014-10-27
First Post:
2006-08-08
Brief Title:
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis DVT and Pulmonary Embolism PE A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
RECORD 3 Study REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE a Controlled Double-blind Randomized Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RECORD 3
Brief Summary:
The purpose of this study is to assess if 10 mg Bay 59-7939 taken once daily as a tablet is safe and prevents blood clot which may form after a knee replacement operation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2005-004620-40 | None | None | None |